| __timestamp | Ascendis Pharma A/S | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19698000 | 241751000 |
| Thursday, January 1, 2015 | 40528000 | 322292000 |
| Friday, January 1, 2016 | 66022000 | 344320000 |
| Sunday, January 1, 2017 | 99589000 | 374644000 |
| Monday, January 1, 2018 | 140281000 | 414604000 |
| Tuesday, January 1, 2019 | 191621000 | 466000000 |
| Wednesday, January 1, 2020 | 260904000 | 535000000 |
| Friday, January 1, 2021 | 295867000 | 643000000 |
| Saturday, January 1, 2022 | 379624000 | 833000000 |
| Sunday, January 1, 2023 | 413454000 | 899625000 |
| Monday, January 1, 2024 | 307004000 | 901530000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc. have been at the forefront of this race, with their R&D spending reflecting their commitment to innovation. Over the past decade, Ionis Pharmaceuticals has consistently outspent Ascendis Pharma, with R&D expenses peaking at nearly 900 million USD in 2023, a staggering 270% increase from 2014. In contrast, Ascendis Pharma's R&D spending grew by over 2000% during the same period, reaching approximately 413 million USD in 2023. This rapid growth highlights Ascendis Pharma's aggressive push towards innovation. While Ionis maintains a higher absolute spend, Ascendis's growth trajectory suggests a strategic pivot towards research-driven development. As these companies continue to invest in R&D, the pharmaceutical landscape is set for exciting advancements.
United Therapeutics Corporation or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ionis Pharmaceuticals, Inc.
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Ascendis Pharma A/S vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Novavax, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
R&D Spending Showdown: Ionis Pharmaceuticals, Inc. vs MorphoSys AG
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs Xencor, Inc.